Figure 1.

Incidence of deaths for all causes in the follow-up period of CA.ME.LI.A population according to—A: glucose tolerance in the whole population: NFG = 1.75%, IFG = 4.52%, DM = 13.53%; B: glucose tolerance in the male population: NFG = 1.9%, IFG = 5.11%, = DM 17.74%; C: glucose tolerance in the female population: NFG = 1.58%, IFG = 3.45%, DM = 9.68%; D: BMI in the whole population: BMI of <25 (NBW) = 1.87%, BMI of >25 (OWO) = 4.41%; E: BMI in the male population: BMI of <25 (NBW) = 1.45%, BMI of >25 (OWO) = 5.82%; F: BMI in the female population: BMI of <25 (NBW) = 2.15%, BMI of >25 (OWO) = 2.43% (In OWO, P = 0.003 between sexes); G: BMI and glucose tolerance in the whole population: NFG/NBW = 1.47%, NFG/OWO = 2.14%, DM/NBW = 3.57%, IFG/NBW = 3.93, IFG/OWO = 4.83%, DM/OWO = 15.6%; H: BMI and glucose tolerance in the male population: NFG/NBW = 1.37%, NFG/OWO = 2.56%, DM/NBW = 0%, IFG/NBW = 1.37%, IFG/OWO = 6.39%, DM/OWO = 18.28%; I: BMI and glucose tolerance in the female population: NFG/NBW = 1.52%, NFG/OWO = 1.68%, DM/NBW = 3.69%, IFG/NBW = 6.67, IFG/OWO = 1.57%, DM/OWO = 10.42%. BMI, body mass index; CA.ME.LI.A, CArdiovascular risks, MEtabolic syndrome, LIver and Autoimmune disease; DM, diabetes mellitus; IFG, impaired fasting glucose; NBW, normal body weight; NFG, normal fasting glucose; OWO, overweight-obese.